FindMyKOL
Clinical trialNCT01060059CompletedObservational

Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

SponsorAstraZenecaEnrollment888Type 2 Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Although the efficacy and safety profile of exenatide has been well established, few data exist on the real world results of exenatide treatment in specific populations and clinical settings. This study is intended to fill this gap through observing and collecting prospective data from a population of Italian patients initiating treatment with either exenatide or basal insulin formulations after failure to achieve glycemic control with oral antihyperglycemic agents (OHA). Observational studies represent noninterventional research; therefore, this study does not involve randomization of patients to particular comparator arms or therapies. The term "noninterventional" means that the healthcare providers decisions regarding the proper treatment and care of the patient are made in the course of normal clinical practice. Patients enrolled in this study are enrolling for the collection of their data on observations made during normal clinical practice.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Italy
  • Research Site

    Acquaviva delle Fonti, Italy

  • Research Site

    Anzio, Italy

  • Research Site

    Bassano del Grappa, Italy

  • Research Site

    Bologna, Italy

  • Research Site

    Brindisi, Italy

  • Research Site

    Cagliari, Italy

  • Research Site

    Campi Salentina, Italy

  • Research Site

    Casarano, Italy

  • Research Site

    Caserta, Italy

  • Research Site

    Cesena, Italy

  • Research Site

    Chieri, Italy

  • Research Site

    Cisternino, Italy

  • Research Site

    Copertino, Italy

  • Research Site

    Cremona, Italy

  • Research Site

    Distretto Vittoria, Italy

  • Research Site

    Fermo, Italy

  • Research Site

    Ferrara, Italy

  • Research Site

    Fidenza, Italy

  • Research Site

    Florence, Italy

  • Research Site

    Forlì, Italy

  • Research Site

    Genova, Italy

  • Research Site

    Germaneto, Italy

  • Research Site

    Lecce, Italy

  • Research Site

    Livorno, Italy

  • Research Site

    Lucca, Italy

  • Research Site

    Manfredonia (Le), Italy

  • Research Site

    Mariano Comense, Italy

  • Research Site

    Messina, Italy

  • Research Site

    Milan, Italy

  • Research Site

    Monza, Italy

  • Research Site

    Naples, Italy

  • Research Site

    Novara, Italy

  • Research Site

    Olbia, Italy

  • Research Site

    Palermo, Italy

  • Research Site

    Palmi, Italy

  • Research Site

    Parma, Italy

  • Research Site

    Pavia, Italy

  • Research Site

    Pisa, Italy

  • Research Site

    Potenza, Italy

  • Research Site

    Rimini, Italy

10 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Basal insulinExenatide →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2010
Primary completion
31 May 2012
Completion
31 May 2012
Last update posted
9 Apr 2015
Registered enrollment
888
Registry id
NCT01060059

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.